Browsing Over 92 Presentations
Sort By
Presentation Number
Biomarker development
2P - Lung Immune Prognostic Index (LIPI) can identify the fast-progressor to immune checkpoints inhibitors (ICI) in microsatellite instability (MSI) or mismatch repair deficient (dMMR) tumours
Room
e-Poster Display
Speakers
- E. Auclin (Paris, France)
Authors
- E. Auclin (Paris, France)
- P. Vuagnat (Villejuif, France)
- C. Smolenschi (Villejuif, France)
- J. Taieb (Paris, France)
- J. Adeva Alfonso (Madrid, Spain)
- L. Nebot (Villejuif, France)
- M. Garcia de Herreros (Barcelona, Spain)
- R. Vidal Tocino (Salamanca, Spain)
- F. Longo (Madrid, Spain)
- Y. El Dakdouki (Villejuif, France)
- P. Martin Romano (Villejuif, France)
- E. Castanon Alvarez (Las Palmas de Gran Canaria, Spain)
- R. Garcia-Carbonero (Madrid, Spain)
- L. Gaba Garcia (Barcelona, Spain)
- T. Sauri Nadal (Barcelona, Spain)
- H. Oliveres (Sabadell, Spain)
- B. Besse (Villejuif, CEDEX, France)
- C. Massard (Villejuif, France)
- L. Mezquita (Barcelona, Spain)
- A. Hollebecque (Villejuif, France)
Biomarker development
3P - Association between inflammation index and nutritional status and the effectiveness of immunotherapy in NSCLC treatment.
Room
e-Poster Display
Speakers
- S. Tolu (Cagliari, Italy)
Authors
- S. Tolu (Cagliari, Italy)
- F. Balconi (Cagliari, Italy)
- N. Liscia (Cagliari, Italy)
- D. Spanu (Cagliari, Italy)
- M. Persano (Cagliari, Italy)
- G. Pinna (Monserrato, Italy)
- M. Dubois (Monserrato, Italy)
- G. Saba (Monserrato, Italy)
- V. Impera (Monserrato, Italy)
- S. Mariani (Monserrato, Italy)
- C. Donisi (Cagliari, Italy)
- A. Pretta (Cagliari, Italy)
- A. Pireddu (Cagliari, Italy)
- F. Musio (Monserrato, Italy)
- M. Migliari (Cagliari, Italy)
- R. Piredda (Monserrato, Italy)
- M. Scartozzi (Monserrato, Italy)
- C. Madeddu (Monserrato, (CA), Italy)
Biomarker development
4P - IgM-Rheumatoid Factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+ T-cells.
Room
e-Poster Display
Speakers
- A. Ugolini (Rome, Italy)
Authors
- A. Ugolini (Rome, Italy)
- I. Zizzari (Rome, Italy)
- F. Ceccarelli (Rome, Italy)
- A. Botticelli (Rome, Italy)
- T. Colasanti (Rome, Italy)
- L. Strigari (Rome, Italy)
- A. Rughetti (Rome, Italy)
- H. Rahimi (Rome, Italy)
- F. Conti (Rome, Italy)
- G. Valesini (Rome, Italy)
- P. Marchetti (Rome, Italy)
- M. Nuti (Rome, Italy)
Biomarker development
5P - Uncovering the evolution of Glioblastoma proteome landscape from primary to the recurrent stage for development of novel diagnostic and predictive biomarkers
Room
e-Poster Display
Speakers
- N. Tatari (Hamilton, Canada)
Authors
- N. Tatari (Hamilton, Canada)
- S. Khan (Toronto, ON, Canada)
- J. Livingstone (Toronto, ON, Canada)
- C. Venugopal (Hamilton, Canada)
- J. Chan (Calgary, AB, Canada)
- C. Hawkins (Toronto, ON, Canada)
- J. Provias (Hamilton, ON, Canada)
- J. Lu (Hamilton, Canada)
- K. Ask (Hamilton, ON, Canada)
- T. Kislinger (Toronto, ON, Canada)
- S. Singh (Hamilton, ON, Canada)
Biomarker development
6P - Role of inflammatory cytokines in distant metastasis of non-small cell lung cancer
Room
e-Poster Display
Speakers
- O. Savelieva (Tomsk, Russian Federation)
Authors
- D. Pismenny (Tomsk, Russian Federation)
- O. Savelieva (Tomsk, Russian Federation)
- L. Tashireva (Tomsk, Russian Federation)
- M. Zavyalova (Tomsk, Russian Federation)
- V. Perelmuter (Tomsk, Russian Federation)
Biomarker development
7P - Peripheral Blood-Based Biomarkers of Prognosis and Treatment Response in Patients with Non-Small Cell Lung Cancer Treated with PD-1 Inhibitors
Room
e-Poster Display
Speakers
- I. Tourkantonis (Athens, Greece)
Authors
- I. Tourkantonis (Athens, Greece)
- D. Grapsa (Athens, Greece)
- A. Charpidou (Athens, Greece)
- I. Gkiozos (Athens, Greece)
- H. Gogas (Athens, Attiki, Greece)
- D. Psyrri (Athens, Greece)
- K. Syrigos (Athens, Greece)
Biomarker development
8P - Immune cell subsets in peripheral blood are associated with primary resistance to immunotherapy as frontline treatment in NSCLC
Room
e-Poster Display
Speakers
- H. Arasanz (Pamplona, Spain)
Authors
- H. Arasanz (Pamplona, Spain)
- M. Zuazo (Pamplona, Spain)
- L. Chocarro (Pamplona, Spain)
- A. Bocanegra Gondan (Pamplona, Spain)
- M. Martínez-Aguillo (Pamplona, Spain)
- I. Morilla (Pamplona, Spain)
- G. Fernández-Hinojal (Pamplona, Spain)
- E. Blanco (Pamplona, Spain)
- L. Teijeira (Pamplona, Spain)
- P. Morente (Pamplona, Spain)
- I. Pedroarena (Pamplona, Spain)
- R. Vera (Pamplona, Spain)
- G. Kochan (Pamplona, Spain)
- D. Escors (Pamplona, Spain)
Biomarker development
9P - Circulating tumor cells (CTCs) count and PD-L1 expression in untreated extensive small cell lung cancer patients treated in the REACTION trial, a phase II study of etoposide and cis/carboplatin with or without pembrolizumab (NCT02580994)
Room
e-Poster Display
Speakers
- J. Menis (Padova, Italy)
Authors
- J. Menis (Padova, Italy)
- P. Bironzo (Torino, Italy)
- G. Radj (Caen, France)
- L. Greillier (Marseille, France)
- I. Monnet (Creteil, France)
- L. Livi (Firenze, Italy)
- R. Young (Sheffield, United Kingdom)
- C. Decroisette (Metz-Tessy, CEDEX, France)
- N. Cloarec (Avignon, France)
- G. Robinet (Brest, France)
- R. Schott (Strasbourg, France)
- R. Califano (Manchester, United Kingdom)
- F. De Marinis (Milan, Italy)
- M. Mauer (Bruxelles, Belgium)
- A. Pochesci (Bruxelles, Belgium)
- M. Silva (Parma, Italy)
- C. Caramella (Orsay, France)
- A. Dingemans (Rotterdam, Netherlands)
- C. Dive (Manchester, United Kingdom)
- B. Besse (Villejuif, CEDEX, France)
Biomarker development
10P - Genomic profiles of CD47 in breast tumors predict outcome and are associated with immune activation and enrichment of pro-tumoral macrophage markers
Room
e-Poster Display
Speakers
- A. Ocaña (Madrid, Spain)
Authors
- A. Ocaña (Madrid, Spain)
- M. Noblejas Lopez (Albacete, Spain)
- M. Baliu-Piqué (Madrid, Spain)
- C. Nieto-Jiménez (Salamanca, Spain)
- F. Cimas (Albacete, Spain)
- E. Morafraile (Madrid, Spain)
- A. Pandiella (Salamanca, Spain)
- Á. Corbí (Madrid, Spain)
- B. Győrffy (Budapest, Hungary)
Biomarker development
12P - The correlation between non-coding RNA and response rate to immune-checkpoint inhibitors.
Room
e-Poster Display
Speakers
- D. Shek (Campbelltown, Australia)
Authors
- D. Shek (Campbelltown, Australia)
- S. Read (Blacktown, NSW, Australia)
- A. Nagrial (Westmead, ACT, Australia)
- M. Carlino (Wollstonecraft, NSW, Australia)
- J. George (Westmead, NSW, Australia)
- B. Gao (Blacktown, NSW, Australia)
- G. Ahlenstiel (Blacktown, Australia)
Biomarker development
13P - PD-L1 prevalence in advanced urothelial carcinoma by demographic and clinical characteristics
Room
e-Poster Display
Speakers
- T. Powles (London, United Kingdom)
Authors
- T. Powles (London, United Kingdom)
- M. Van der Heijden (Amsterdam, Netherlands)
- A. Balar (New York, United States of America)
- P. O'Donnell (Chicago, IL, United States of America)
- C. Massard (Villejuif, France)
- J. Walker (Royston, United Kingdom)
- A. Gupta (Gaithersburg, United States of America)
- N. Angra (Gaithersburg, MD, United States of America)
- J. Cairns (Cambridge, United Kingdom)
- B. Turriziani (Cambridge, United Kingdom)
- M. Rebelatto (Gaitherburg, United States of America)
- M. Scott (Cambridge, United Kingdom)
- S. Wildsmith (Cambridge, United Kingdom)
Biomarker development
14P - High CMTM6 and PD-L1 co-expression predict metastasis and poor prognosis in esophageal squamous cell carcinoma
Room
e-Poster Display
Speakers
- Y. Luo (Beijing, China)
Authors
- Y. Luo (Beijing, China)
- C. Zhang (Beijing, China)
- Z. Zhang (Beijing, China)
- G. Zhang (Beijing, China)
- L. Xue (Beijing, China)
- Q. Zeng (Beijing, China)
- Q. Xue (Beijing, China)
- S. Gao (Beijing, China)
- N. Sun (Beijing, China)
- J. He (Beijing, China)